Mexico may not follow FDA and approve remdesivir for COVID-19
WHO Solidarity drug trial last week concluded remdesivir has little or no impact on a patient’s chances of surviving COVID-19
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
COFEPRIS
Zydus receives approval from COFEPRIS to conduct clinical trials for COVID-19 treatment therapy
Zydus had earlier approached the DCGI to investigate the role of Pegylated Interferon alpha-2b for COVID 19 and the clinical…
Zydus gets nod from COFEPRIS, Mexico to study Desidustat for COVID-19 management
As a part of the study, 100 mg tablets of Desidustat will be administered for a period of 14 days along with recommended standard…
Building super brands
Known as the 'Sinarest company', Mumbai-based Centaur Pharma has proved that super brands can be nurtured by mid-sized pharma…
Dengue vaccine Dengvaxia approved in Mexico
First marketing authorization of Dengvaxia is a historic milestone paving the way to significantly impact dengue burden in endemic…